Citadel Advisors’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
BIP
Citadel Advisors's PBH Position: Q2 2026 in Review
Citadel Advisors increased its Prestige Consumer Healthcare (PBH) stake by 208% in Q2 2026, buying an estimated $19.6M and bringing the position to 564,157 shares worth $26.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2234.
Citadel Advisors first reported a position in PBH in Q2 2013 and has held it in 47 quarters since. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Citadel Advisors held 564,157 shares of Prestige Consumer Healthcare worth $26.7M as of Q2 2026.
- Citadel Advisors bought 380,717 Prestige Consumer Healthcare shares in Q2 2026, an estimated $19.6M.
- Prestige Consumer Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #2234 holding.
- Citadel Advisors first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 47 quarters since.
- 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.